Synopsis of recent research by authors named "Kevin Flurkey"
- Kevin Flurkey's research predominantly focuses on lifespan extension in various mouse models, exploring the effects of different compounds (such as astaxanthin, meclizine, and rapamycin) on longevity and metabolic health in aging populations.
- Significant findings include that astaxanthin extended male lifespan by 12% and meclizine by 8% in UM-HET3 mice, while 17-α-estradiol showed a remarkable 19% increase in lifespan for the same cohort.
- Additionally, Flurkey's studies investigate the interactions between drugs like rapamycin and metformin to improve insulin sensitivity and mitigate complications of metabolic syndrome in type 2 diabetic mice, reflecting a comprehensive exploration of aging-related health improvements.
